Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VistaGen Therapeutics
Biotech
Incyte, FDA, Sun Pharma and more—Chutes & Ladders
Incyte CEO passes the baton to veteran dealmaker. String of FDA leadership shake-ups continues. Sun Pharma sees future with new North America CEO.
Zoey Becker
,
Gabrielle Masson
Jun 27, 2025 8:30am
Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders
Aug 25, 2023 9:30am
Vistagen stock soars 1,272% on social anxiety spray data
Aug 7, 2023 11:38am
VistaGen's social anxiety nasal spray finds open-label success
Mar 22, 2023 3:36pm
Vistagen pauses anxiety trial restart after seeing rivals fail
Feb 8, 2023 6:20am
Vistagen buys Pherin, wiping out existing licensing deals
Dec 21, 2022 10:45am